Newlink Genetics reported $5.24M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US $ 163.06M 6.12M
Bristol Myers Squibb BMY:US $ 22821M 953M
Capricor Therapeutics CAPR:US $ 14.32M 10.19M
Celldex Therapeutics CLDX:US $ 14.56M 1.97M
Eli Lilly And LLY:US $ 13386M 1666.7M
Idera Pharmaceuticals IDRA:US $ 3.8M 1.07M
Intrexon XON:US $ 25.6M 9.04M
Merk MRK:US $ 22316M 1556M
Nektar Therapeutics NKTR:US $ 105.28M 20.08M
Newlink Genetics NLNK:US $ 5.24M 0.11M
Pfizer PFE:US $ 39268M 3403M
Prothena PRTA:US 36.5M 3.04M
Sarepta Therapeutics SRPT:US $ 454.96M 2.23M
Vascular Biogenics VBLT:US 11.05M 1.12M
YTE INCY:US $ 886.16M 31.86M